CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,320,500 | -26.7% | 6,450,000 | -2.3% | 1.17% | -29.7% |
| Q2 2023 | $11,352,000 | +23.4% | 6,600,000 | +8.3% | 1.67% | +21.9% |
| Q1 2023 | $9,200,478 | +63.8% | 6,093,032 | +73.6% | 1.37% | +68.0% |
| Q4 2022 | $5,616,712 | +10.7% | 3,510,445 | +0.3% | 0.82% | +31.2% |
| Q3 2022 | $5,075,000 | +163.0% | 3,500,000 | +231.9% | 0.62% | +112.3% |
| Q2 2022 | $1,930,000 | +192.4% | 1,054,673 | +592.3% | 0.29% | +120.3% |
| Q4 2021 | $660,000 | -12.1% | 152,345 | +35.0% | 0.13% | -2.2% |
| Q3 2020 | $751,000 | -69.9% | 112,880 | -62.4% | 0.14% | -44.0% |
| Q2 2020 | $2,499,000 | +8.6% | 300,000 | 0.0% | 0.24% | -24.8% |
| Q1 2020 | $2,301,000 | – | 300,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |